Abstract
No public abstract is available from the verified source records.
Ward Jacobs, Klarinda de Zwaan, Luco Rutten, Thierry van Wessel, Thomas J. Boltje, Laia Querol Cano, Christian Büll, Nico Sommerdijk, Lorenzo Albertazzi, Roland Brock
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Clinical development of therapeutic mRNA applications
10.1016/j.ymthe.2025.03.034 · 2025
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
10.1038/s41392-024-02002-z · 2024
Lipid nanoparticles for mRNA delivery
10.1038/s41578-021-00358-0 · 2021
Clinical advances of mRNA vaccines for cancer immunotherapy
10.1016/j.medj.2024.11.015 · 2025
The clinical progress of mRNA vaccines and immunotherapies
10.1038/s41587-022-01294-2 · 2022
Recent advances in mRNA-LNP delivery systems for extrahepatic organs: a review
10.1021/acs.molpharmaceut.5c00385 · 2025
Biological recognition and cellular trafficking of targeted RNA-lipid nanoparticles
10.1016/j.copbio.2023.103041 · 2024
Steering siglec–sialic acid interactions on living cells using bioorthogonal chemistry
10.1002/anie.201612193 · 2017
Siglec-mediated regulation of immune cell function in disease
10.1038/nri3737 · 2014
Mutual regulation between glycosylation and transforming growth factor-β isoforms signaling pathway
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1016/j.ijbiomac.2023.123818 · 2023
Glycocalyx micro- and nanodomains in cell-cell and cell-matrix interactions revealed by enhanced click chemistry
10.1038/s41467-026-69242-1 · 2026
The role of lipid components in lipid nanoparticles for vaccines and gene therapy
10.1016/j.addr.2022.114416 · 2022
Cationic lipid-mediated gene transfer: analysis of cellular uptake and nuclear import of plasmid DNA
10.1023/a:1007425803756 · 1998
Deciphering structural determinants distinguishing active from inactive cell-penetrating peptides for cytosolic mRNA delivery
10.1021/acs.bioconjchem.3c00346 · 2023
Heparin modulates the cellular uptake of nanomedicines
10.1039/d0bm01946a · 2021
Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo*
10.1074/jbc.273.40.26164 · 1998
In vivo endothelial cell gene silencing by siRNA-LNPs tuned with lipoamino bundle chemical and ligand targeting
10.1002/smll.202400643 · 2024
Cell-penetrating peptide exploited syndecans
10.1016/j.bbamem.2010.01.022 · 2010
The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides
2014
Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake
10.1016/j.jconrel.2013.05.001 · 2013
Sweet and bright: illuminating glycoprotein-mediated endocytosis via metabolic labeling and NanoLuciferase
10.1021/acschembio.6c00344 · 2026
Effect of cell-surface glycosaminoglycans on cationic carrier combined with low-MW PEI-mediated gene transfection
10.1016/j.ijpharm.2004.07.023 · 2004
Contribution of syndecans to lipoplex-mediated gene delivery
10.1016/j.ejps.2013.05.022 · 2013
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
10.1038/mt.2010.85 · 2010
Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo
10.1038/s41467-025-63726-2 · 2025
On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles
10.1073/pnas.2109256118 · 2021
Physical−chemical aspects of protein Corona: relevance to in vitro and in vivo biological impacts of nanoparticles
10.1021/ja107583h · 2011
An investigation of the effect of the protein corona on the cellular uptake of nanoliposomes under flow conditions using quartz crystal microgravimetry with dissipation
10.1039/d4na00783b · 2025
Molecular parameters of siRNA–cell penetrating peptide Nanocomplexes for efficient cellular delivery
10.1021/nn305754c · 2013
The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse
10.1016/j.bbrc.2004.12.137 · 2005
Lipid nanoparticlesfrom liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement
10.1021/acsnano.1c04996 · 2021
Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions
10.1073/pnas.1106420108 · 2011
Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
10.1194/jlr.r800069-jlr200 · 2009
Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein E/low density lipoprotein receptor and the N-acetyl-d-galactosamine/asialoglycoprotein receptor pathway
10.1016/j.jconrel.2020.03.006 · 2020
Optimized protocol for efficient transfection of dendritic cells without cell maturation
2011
Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells
10.1038/sj.gt.3300626 · 1998
Deciphering the biological fate of mRNA-LNP-based biologics: a perspective from tissue to intracellular distribution
10.1016/j.apsb.2025.11.023 · 2026
The dynamic process of mRNA delivery by lipid nanoparticles in vivo
10.1016/j.nantod.2024.102325 · 2024
Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity
10.1038/s41467-024-54877-9 · 2024
Identification of global inhibitors of cellular glycosylation
10.1038/s41467-023-36598-7 · 2023
Controlling nanoparticle uptake in innate immune cells with Heparosan polysaccharides
10.1021/acs.nanolett.2c02226 · doi-reference
CD44-targeted lipid nanoparticles for enhanced CRISPR/Cas9 delivery in cancer gene editing
10.1016/j.jconrel.2025.114598 · doi-reference
Cholesterol-derived mannosylated polypeptide-formed lipid nanoparticles for efficient in vivo mRNA delivery
10.1002/smtd.202401712 · doi-reference
Targeting nanoparticles to lung cancer-derived A549 cells based on changes on interstitial stiffness in biomimetic models
10.1016/j.isci.2024.111015 · doi-reference
A lipid nanoparticle-based oligodendrocyte-specific mRNA therapy
10.1016/j.omtn.2024.102380 · doi-reference
Computationally aided design of ionizable cholesteryl lipids for lipid nanoparticles to modulate hepatic mRNA accumulation
10.1021/jacs.5c14870 · doi-reference
Albumin–hyaluronan interactions: influence of ionic composition probed by molecular dynamics
10.3390/ijms222212360 · doi-reference
Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery to the retina
10.1021/acs.molpharmaceut.6b01029 · doi-reference
Influence of serum albumin on intracellular delivery of drug-loaded hyaluronan polymeric micelles
10.1016/j.ijpharm.2016.07.057 · doi-reference
A human pan-disease blood atlas of the circulating proteome
10.1126/science.adx2678 · doi-reference
An enzyme-linked immunosorbent assay method to measure human apolipoprotein E levels using commercially available reagents: effect of apolipoprotein E polymorphism on serum apolipoprotein E concentration
10.1006/abio.1994.1576 · doi-reference
The structural role of N-linked Glycans on human Glypican-1
10.1021/bi200218s · doi-reference
CNS delivery via adsorptive transcytosis
10.1208/s12248-008-9055-2 · doi-reference
Introducing a single-point modification to the cell-penetrating peptide PepFect14 analogue sequence for optimising oligonucleotide delivery
10.1007/s12668-025-02002-5 · doi-reference
Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: implications for uptake
10.1016/j.jconrel.2010.06.030 · doi-reference
Structure–uptake relationship study of DABCYL derivatives linked to cyclic cell-penetrating peptides for live-cell delivery of synthetic proteins
10.1002/anie.202207551 · doi-reference
Internalisation and biological activity of nucleic acids delivering cell-penetrating peptide nanoparticles is controlled by the biomolecular corona
10.3390/ph14070667 · doi-reference
The role of endocytosis in the uptake and intracellular trafficking of PepFect14–nucleic acid nanocomplexes via class a scavenger receptors
10.1016/j.bbamem.2015.09.019 · doi-reference
An apolipoprotein-enriched biomolecular corona switches the cellular uptake mechanism and trafficking pathway of lipid nanoparticles
10.1039/c7nr06437c · doi-reference
Surface adsorption of protein corona controls the cell internalization mechanism of DC-Chol–DOPE/DNA lipoplexes in serum
10.1016/j.bbamem.2009.11.007 · doi-reference
Mechanism of oligonucleotide release from cationic liposomes
10.1073/pnas.93.21.11493 · doi-reference
An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery
10.1126/science.281.5373.78 · doi-reference
Interaction kinetics of individual mRNA-containing lipid nanoparticles with an endosomal membrane mimic: dependence on pH, protein Corona formation, and lipoprotein depletion
10.1021/acsnano.2c04829 · doi-reference
A novel role for 3-O-sulfated Heparan sulfate in herpes simplex virus 1 entry
10.1016/s0092-8674(00)80058-6 · doi-reference
Sulfated K5 Escherichia coli polysaccharide derivatives: a novel class of candidate antiviral microbicides
10.1016/j.pharmthera.2009.05.001 · doi-reference
Metabolic oligosaccharide engineering with alkyne sialic Acids confers neuraminidase resistance and inhibits influenza reproduction
10.1021/acs.bioconjchem.7b00224 · doi-reference
SARS-CoV-2 infection depends on cellular Heparan sulfate and ACE2
10.1016/j.cell.2020.09.033 · doi-reference
Key design features of lipid nanoparticles and electrostatic charge-based lipid nanoparticle targeting
10.3390/pharmaceutics15041184 · doi-reference
LDLR, LRP1, and megalin redundantly participate in the uptake of Clostridium novyi alpha-toxin
10.1038/s42003-022-03873-0 · doi-reference
Up-regulation of hepatic low-density lipoprotein receptor–related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl–coenzyme a reductase inhibitor: atorvastatin and hepatic LRP1 expression
10.1016/j.metabol.2010.08.013 · doi-reference
Dendritic cell-targeted tumor antigen delivery by glucosylated lipid nanoparticles for precision tumor immunotherapy
10.1016/j.jconrel.2026.114671 · doi-reference
Structure–activity-driven multicompartment lipid nanoparticles for synergistic mRNA and siRNA Codelivery in acute myeloid leukemia
10.1021/jacs.5c23209 · doi-reference
mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression
10.1038/s41587-026-03099-z · doi-reference
Heparan sulfates in skeletal muscle development and physiology
10.1002/jcp.20450 · doi-reference
Acute UV irradiation increases Heparan sulfate proteoglycan levels in human skin
10.3346/jkms.2012.27.3.300 · doi-reference
Lipid nanoparticles as a tool to dissect dendritic cell maturation pathways
10.1016/j.celrep.2025.116150 · doi-reference
Lipid nanoparticle acts as a potential adjuvant for influenza split vaccine without inducing inflammatory responses
10.3390/vaccines8030433 · doi-reference
Cationic lipid nanocarriers activate toll-like receptor 2 and NLRP3 inflammasome pathways
10.1016/j.nano.2013.12.003 · doi-reference
CORE: cholesterol altered lipid nanoparticles for splenic expression of mRNA payloads
10.1002/adhm.202505862 · doi-reference
Lipid nanoparticles containing labile PEG-lipids transfect primary human skin cells more efficiently in the presence of apoE
10.1016/j.ejpb.2024.114219 · doi-reference